Literature DB >> 2947345

Oral progesterone treatment in chronic obstructive lung disease: failure of voluntary hyperventilation to predict response.

D A Morrison, A L Goldman.   

Abstract

Previous studies have shown that some patients with chronic obstructive lung disease and hypercapnia will respond to medroxyprogesterone with improvement in arterial blood gases. The exact mechanism of this effect is unclear but it is presumed to be a result of ventilatory stimulation. To determine whether the ability to correct arterial blood gas abnormalities by voluntary hyperventilation would predict a subsequent favourable response to progesterone, we studied 11 subjects with chronic obstructive lung disease and chronic hypercapnia. Five subjects had chronic obstructive lung disease of moderate severity with mean (SE) FEV1 1.8 (0.34) 1 maximum voluntary ventilation (MVV) 40.4 (7.16) 1/min-1, arterial oxygen tension (Pao2) 53.8 (2.40 mm Hg, and arterial carbon dioxide tension Paco2) 49.6 (3.91) mm Hg, and were able to normalise their blood gas tensions during voluntary hyperventilation (Pao2 85.4 (8.01) mm Hg; Paco2 32.8 (3.43) mm Hg). Six subjects had severe chronic obstructive lung disease with FEV1 0.77 (0.12) 1, MVV 19 (3.09) 1/min-1, Pao2 60.0 (2.89) mm Hg and Paco2 50.5 (1.38) mm Hg, and they could not significantly alter their blood gases with voluntary hyperventilation (Pao2 62.5 (3.19) mm Hg, Paco2 49.7 (1.84) mm Hg). The groups were similar in age, height, weight, and resting Pao2 and Paco2. Each subject received one month of oral placebo and one month of medroxyprogesterone acetate (Provera). 20 mg orally thrice daily, given in a randomised, double blind fashion. The groups responded similarly with a significantly higher Pao2 and lower Paco2 while having medroxyprogesterone acetate than while having placebo. Two patients with polycythaemia showed a reduction in haemoglobin concentration while taking progesterone. It is concluded that the response to medroxyprogesterone is not predictable from spirometric or blood gas changes after voluntary hyperventilation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2947345      PMCID: PMC460407          DOI: 10.1136/thx.41.8.616

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  13 in total

1.  MECHANISMS OF CHRONIC CARBON DIOXIDE RETENTION IN PATIENTS WITH OBSTRUCTIVE PULMONARY DISEASE.

Authors:  R GILBERT; J KEIGHLEY; J H AUCHINCLOSS
Journal:  Am J Med       Date:  1965-02       Impact factor: 4.965

2.  The Veterans Administration-Army cooperative study of pulmonary function. I. Clinical spirometry in normal men.

Authors:  R C KORY; R CALLAHAN; H G BOREN; J C SYNER
Journal:  Am J Med       Date:  1961-02       Impact factor: 4.965

3.  The respiratory effects of progesterone in severe pulmonary emphysema.

Authors:  J H CULLEN; V C BRUM; W U REIDT
Journal:  Am J Med       Date:  1959-10       Impact factor: 4.965

4.  The work of breathing.

Authors:  A B OTIS
Journal:  Physiol Rev       Date:  1954-07       Impact factor: 37.312

5.  Blood gas changes during voluntary hyperventilation in normal and disease states.

Authors:  A Rotsztain; R Haddad; H G Canter
Journal:  Am Rev Respir Dis       Date:  1970-08

6.  Therapeutic use of progesterone in alveolar hypoventilation associated with obesity.

Authors:  H A Lyons; C T Huang
Journal:  Am J Med       Date:  1968-06       Impact factor: 4.965

7.  Idiopathic alveolar hypoventilation: clinical spectrum.

Authors:  G G Rhoads; J S Brody
Journal:  Ann Intern Med       Date:  1969-08       Impact factor: 25.391

8.  Medroxyprogesterone acetate and COPD. Effect on breathing and oxygenation in sleeping and awake patients.

Authors:  F R Dolly; A J Block
Journal:  Chest       Date:  1983-10       Impact factor: 9.410

9.  Determinants of chronic carbon dioxide retention and its correction in humans.

Authors:  J B Skatrud; J A Dempsey; P Bhansali; C Irvin
Journal:  J Clin Invest       Date:  1980-04       Impact factor: 14.808

10.  Correction of CO2 retention during sleep in patients with chronic obstructive pulmonary diseases.

Authors:  J B Skatrud; J A Dempsey; C Iber; A Berssenbrugge
Journal:  Am Rev Respir Dis       Date:  1981-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.